Nuclear-targeted siRNA delivery for long-term gene silencing

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Nanotechnology

Background:

• Developing effective nonviral small interfering RNA (siRNA) delivery systems for sustained gene silencing in cancer therapy is a significant challenge.
• Current methods often face limitations in achieving long-lasting therapeutic effects.

Purpose of the Study:

• To develop and evaluate a nuclear-targeted siRNA delivery system for inducing long-term gene silencing in cancer cells.
• To investigate the potential of this system in inhibiting cancer cell proliferation and tumor formation.

Main Methods:

• Gold nanoparticles were functionalized with synthetic siRNAs and nuclear localization signal (NLS) peptides.
• The NLS peptides facilitated nuclear translocation of the nanocarrier.
• siRNA targeted the thymidine kinase 1 promoter, triggering RNA-directed DNA methylation for gene silencing.

Main Results:

• The nuclear-targeted nanocarrier achieved gene knockdown lasting over 30 days, significantly longer than cytoplasmic delivery.
• This long-term gene silencing effectively inhibited cancer cell proliferation.
• The system demonstrated efficacy in preventing tumor formation in a mouse model.

Conclusions:

• Nuclear-targeted siRNA delivery systems offer a promising strategy for achieving durable gene silencing in cancer.
• This approach holds potential for developing advanced cancer therapies with prolonged efficacy.
• The developed nanocarrier system represents a significant advancement in nonviral gene silencing technologies.